Liquidia Settles United Therapeutics Suits With $380.7M Deal
Liquidia will pay out $380.7 million as part of a settlement agreement with United Therapeutics Corp. that resolves six lawsuits between the pharmaceutical companies, Liquidia announced Tuesday, saying patient... (more story)
FTC Wants Shkreli Sanctioned Over Pharma Industry Ban
The Federal Trade Commission and seven states asked a New York federal judge Tuesday to hold Martin Shkreli in contempt for violating a court order banning him from the pharmaceutical industry by trading in in... (more story)
Facing Mandatory Fed Price Program, Pharma Goes To Court
The first major lawsuit focused on "most favored nation" drug pricing efforts hit the courts last week. A bigger fight might be ahead as more mandatory programs emerge.
Health Co. Mirra-Access Hits Ch. 11 To Deal With $400M Loan
Healthcare company Mirra-Access is seeking Chapter 11 protection in a Florida bankruptcy court with more than $100 million in debt and plans to restructure a loan facility with a firm tied to Franklin Templeton.
Dentons Adds K&L Gates Lawyer To Healthcare Practice In DC
Dentons has hired a former K&L Gates LLP counsel as a partner in its Washington, D.C., office, where he will advise pharmaceutical, biotechnology and medical device companies on a range of matters related to r... (more story)
TRex Bio Leads 2 Drugmakers Pricing IPOs Totaling $162M
Two clinical-stage biotechnology firms, TRex Bio and Retension Pharmaceuticals, hit the public markets on Friday after raising a combined $162 million in their initial public offerings.